AUDHYA PAUL K. (Chief Medical Officer) sold 0.9% of their position (1.16K shares) of KALVISTA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $17.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/19/2026ACC: 0001860131-26-000002
Officer· Chief Medical Officer
Since May 2021
-1.16K
Net shares
Net seller
$17.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2.42K acquired · 3.58K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.42K
Price / share
—
Trade value
—
% of position
1.8%
2/17/2026
131.83K→134.25K
Common Stock
Direct
Shares
−1.16K
Price / share
$15.00
Trade value
$17.45K
% of position
0.9%
2/18/2026
134.25K→133.09K
Total
Net shares
+1.26K
Net value
-$17.45K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/17/2026 | M · Option Exercise | +2.42K | — | — | 1.8% | 131.83K | 134.25K |
| Common Stock Direct | 2/18/2026 | S · Sale | −1.16K | $15.00 | $17.45K | 0.9% | 134.25K | 133.09K |
| Total | +1.26K | -$17.45K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
2.42K shares
Shares
−2.42K
Strike price
Held after
2.42K
Exercisable
—
2/17/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock2.42K shares | 2/17/2026 | M · Option Exercise | −2.42K | — | 2.42K |